β-Catenin expression pattern in stage I and II ovarian carcinomas: Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 527-536

  Gamallo, Carlos ^a   Palacios, José ^a   Moreno, Gema ^a   De Mora, Jorge Calvo ^a   Suárez, Asunción ^a   Armas, Alvaro ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASEIN KINASE;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; EARLY CANCER; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032813907     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65148-6     Document Type: Article

References (55)

1. Parker SL, Tong T, Beiden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997, 47:5-27
2. Canistra SA: Cancer of the ovary. N Engl J Med 1993, 329:1550-1559
3. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K: Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990, 75:263-273
4. Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Tropé CG: Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol 1993, 169:40-52
5. Pieretti M, Powell DE, Gallion HH, Case EA, Conway PS, Turker MS: Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors. Hum Pathol 1995, 26:393-397
6. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J: K-ras mutations in mucinous ovarian tumors: a clinicopathological and molecular study of 95 cases. Cancer 1997, 79:1581-1586
7. Palacios, Gamallo C: Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 1998, 58:1344-1347
8. Bath AIM, Nätke IS, Nelson WJ: Cadherins, catenins, and APC protein: interplay between cytoeskeletal complexes and signalling patways. Curr Opin Cell Biol 1997, 9:683-690
9. Ilyas M, Tomlison IPM: The interaction of APC, E-cadherin and β-catenin in tumor development and progression. J Pathol 1997, 182:128-137
10. Pignatelli M: E-cadherin: a biological marker of tumour differentiation. J Pathol 1993, 171:81-82
11. Takeichi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993, 5:806-811
12. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M: E-cadherin mediated adhesion system in cancer cells. Cancer 1996, 77:1605-1613
13. Hirohashi S: Inactivation of E-cadherin mediated cell adhesion system in human cancers. Am J Pathol 1998, 153:333-339
14. Korinek V, Barker N, Morin PJ, Van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-l-colon carcinoma. Science 1997, 275:1784-1787
15. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R: β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16:3797-3804
16. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P: Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996, 272:1023-1026
17. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
18. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792
19. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S: Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 1996, 56:2213-2217
20. Ilyas M, Tomlison IPM, Rowan A, Pignatelli M, Bodmer WF: β-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997, 94:10330-10334
21. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hausner P, DeNobile JW, Soballe PW, Kirsch IR: Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 1997, 4478-4481
22. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y, Miyoshi Y: Activation of the β-catenin gene by interstitial deletion involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 1998, 58:1021-1026
23. Spark AB, Morin PJ, Volgestein B, Kinzler KW: Mutational analysis of APC/β-catenin/Tcf patway in colorectal cancer. Cancer Res 1998, 58:1130-1134
24. Voeller HJ, Truica CI, Gelman EP: β-catenin mutations in prostate cancer. Cancer Res 1998, 2520-2523
25. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y: Activation of β-catenin gene in primary hepatocellular carcinomas by somatic alteration involving exon 3. Cancer Res 1998, 58:2524-2527
26. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hiroashi S: β-catenin mutations in carcinoma of the uterine endometrium. Cancer Res 1998, 58:3526-3528
27. Zurawel RH, Chiappa SA, Allen C, Raffel C: Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res 1998, 58: 896-899
28. Gamallo C, Palacios J, Suárez A, Pizarro A, Navarro P, Quintanilla M, and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993, 142:987-993
29. Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C: Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression, and pathological features. Am J Pathol 1995, 146:605-612
30. Bell DA, Scully RE: Early de novo ovarian cancer: a study of fourteen cases. Cancer 1994, 73:1859-1864
31. Puis LE, Powel DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, van Nagell JR Jr: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol 1992, 47:53-57
32. Roth LM, Czernobilsky B, Langley FA: Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors: benign, proliferating and malignant. Cancer 1981, 48:1838-1845
33. Bell DA, Scully RE: Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases. Am J Surg Pathol 1985, 9:205-214
34. Snyder RR, Norris HJ, Tavassoli F: Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary. A clinicopathological study of 46 cases. Am J Surg Pathol 1989, 12: 661-671
35. Norris HJ: Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary. Int J Gynecol Pathol 1993, 12:134-140
36. Candidas S, Bischoff P, Becker KF, Höfler H: No evidence for mutations in the α-and β-catenin genes in human gastric and breast cancer. Cancer Res 1996, 56:49-36
37. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K: β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998, 58: 42-46
38. Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M: High frequency of β-catenin (Ctnnb1) mutation in colon tumors induced by two heterocyclic amines in the F334 rat. Cancer Res 1998, 58:1127-1128
39. Peifer M, Pai LM, Casey M: Phosphorylation of the Drosophila adherens junction protein Armadillo: roles of Wingless signal and Zestewhit 3 kinase. Dev Biol 1994, 543-546
40. Huget EL, McMahon JA, McMahon AP, Bicknell R, Harris AL: Differential expression of human Wnt genes 2,3,4, and 7b in human breast cell lines and normal and disease state of human breast tissue. Cancer Res 1994, 54:2615-2621
41. Iozzo RV, Eichteiter I, Danielson KG: Aberrant expression of the growth factor Wnt 5A in human malignancy. Cancer Res 1995, 55: 1495-3499
42. Valizadeh A, Karayiannakis AJ, El-Hariry I, Kmiot W, Pignatelli M: Expression of E-cadherin associated molecules (α, β, and γ-catenins and p120) in colorectal polyps. Am J Pathol 1997, 150:1977-1984
43. Alman BA, Li C, Pajerski ME, Díaz-Cano S, Wolfe HJ: Increased β-catenin protein, and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997, 151:324-329
44. Allan GJ, Cottrell S, Trowsdale J, Foulkes WD: Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22. Hum Mutat 1994, 3:283-291
45. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukit S, Shibamoto S, Ito F, Takeichi M, Matsuda H, Hiroashi S: A truncated β-catenin disrupts the interaction between E-cadherin and β-catenin. A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994, 54:6282-6287
46. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu Y: Loss of E-cadherin-dependent cell-adhesion due to mutation of β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995, 15: 1175-1181
47. Andrews NA, Jones AS, Heliwell TR, Kinsella AR: Expression of E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997, 75:1474-1480
48. Krishnadath K, Tilanus HW, Van Blankestein M, Hop WCJ, Kremer ED, Dinjens WND Bosman FT: Reduced expression of the cadherin/ catenin complex in oesophageal adenocarcinomas correlates with poor prognosis. J Pathol 1997, 182:331-338
49. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S: Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinoma and its prognostic significance. Oncology 1997, 54:158-165
50. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing M: Abnormal immunoreactivity of E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997, 112:46-54
51. Hao X, Tomlinson I, Ilyas M, Palazzo JP, Talbot IC: Reciprocity between membranous and nuclear expression of b-catenin in colorectal tumors. Virchows Arch 1997, 431:167-172
52. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T: Expression of β-catenin in normal breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996, 29:139-146
53. Fujimoto J, Ichigo S, Hirose R, Sakaguchi H, and Tamaya T: Expression of E-cadherin and α-and β-catenin mRNAs in ovarian cancers. Cancer Lett 1997, 115:207-212
54. Davies BR, Worsley SD, Ponder BAJ: Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancer. Histopathology 1998, 32:69-80
55. Anttila M, Kosma V-M, Ji H, Wei-Ling X, Puolakka J, Juhola M, Saarikoski S, Syrjänen K: Clinical significance of α-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol 1998, 16:2591-2600